HYALGAN® - Proven Efficacy

shoe image

The proof of efficacy goes on


HYALGAN® registration trials consistently demonstrate efficacy


Efficacy demonstrated in placebo-controlled trials10 YES
Efficacy demonstrated in a controlled US study (met primary efficacy end point with statistical significance)10 YES
Efficacy demonstrated in the largest US controlled study of any hyaluronan10,30-31 YES
Individual study results demonstrate efficacy (ie, no pooling of data required to show statistical difference)10 YES
Demonstrated efficacy with 5-injection and 3-injection regimens*8,11 YES
Demonstrated 3 injection efficacy in 3 placebo controlled trials*10,30-31 YES
  • Demonstrated efficacy versus active comparators in multiple clinical trials8,14,35-36
  • 100 published studies17

*Some patients may experience benefit with 3 injections given at weekly intervals. This has been noted in studies of patients receiving 3 injections who were followed for 60 days.10


Important Safety Information for HYALGAN®

  • HYALGAN® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpha-rmacologic therapy, and to simple analgesics, eg, acetaminophen
  • HYALGAN® is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site
  • The effectiveness of a single treatment cycle of less than 3 injections has not been established
  • In the US clinical trial of 495 patients, the only adverse event showing statistical significance vs placebo was injection-site pain
  • Other adverse events included gastrointestinal complaints, headache, local ecchymosis and rash, local joint pain and swelling, and local pruritus. However, the incidence of these events was similar in the HYALGAN®-treated and placebo groups
  • In other clinical studies, the frequency and severity of adverse events occurring during repeat treatment cycles did not increase over that reported for a single treatment cycle

Click here for additional important information for HYALGAN®.